| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
389 |
346 |
$9K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
796 |
592 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
293 |
238 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
627 |
503 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
64 |
58 |
$2K |
| 86328 |
|
56 |
55 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
346 |
242 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
12 |
$555.28 |
| 99349 |
|
60 |
58 |
$492.63 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12 |
12 |
$339.72 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
112 |
106 |
$225.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32 |
27 |
$172.76 |
| 99350 |
Prolong home eval add 15m |
38 |
31 |
$155.68 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
112 |
106 |
$136.86 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
112 |
106 |
$74.72 |
| 90686 |
|
29 |
24 |
$38.52 |
| 99490 |
Ccm add 20min |
88 |
83 |
$36.01 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
124 |
117 |
$28.72 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
112 |
106 |
$27.38 |
| 87640 |
|
112 |
106 |
$27.38 |
| 96127 |
|
21 |
13 |
$4.72 |
| 99407 |
|
12 |
12 |
$0.00 |
| 87486 |
|
112 |
106 |
$0.00 |
| 87498 |
|
112 |
106 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
14 |
14 |
$0.00 |
| 87634 |
|
112 |
106 |
$0.00 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
112 |
106 |
$0.00 |